Targeting the ICOS/ICOS-L pathway in a mouse model of established allergic asthma disrupts T follicular helper cell responses and ameliorates disease.
Uwadiae, Faith I
Targeting the ICOS/ICOS-L pathway in a mouse model of established allergic asthma disrupts T follicular helper cell responses and ameliorates disease. [electronic resource] - Allergy 04 2019 - 650-662 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1398-9995
10.1111/all.13602 doi
Animals
Asthma--drug therapy
B-Lymphocytes--immunology
Female
Germinal Center--immunology
Inducible T-Cell Co-Stimulator Ligand--antagonists & inhibitors
Inducible T-Cell Co-Stimulator Protein--antagonists & inhibitors
Lung--pathology
Mice
Mice, Inbred BALB C
Pyroglyphidae--immunology
T-Lymphocytes, Helper-Inducer--immunology
Targeting the ICOS/ICOS-L pathway in a mouse model of established allergic asthma disrupts T follicular helper cell responses and ameliorates disease. [electronic resource] - Allergy 04 2019 - 650-662 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1398-9995
10.1111/all.13602 doi
Animals
Asthma--drug therapy
B-Lymphocytes--immunology
Female
Germinal Center--immunology
Inducible T-Cell Co-Stimulator Ligand--antagonists & inhibitors
Inducible T-Cell Co-Stimulator Protein--antagonists & inhibitors
Lung--pathology
Mice
Mice, Inbred BALB C
Pyroglyphidae--immunology
T-Lymphocytes, Helper-Inducer--immunology